It seems we are at a crossroads when lifesaving treatments, while not yet approved, exist but patient cannot have access.
Michael Burgess: “It seems we are at a crossroads when lifesaving treatments, while not yet approved, exist but patient cannot have…”
Editor's note · Context
Burgess highlights the dilemma of access to unapproved lifesaving treatments.
Share
More from Michael Burgess
I will simply underscore the fact that entry- level chemists at the EPA are hired at much higher than the GSA rate. These are not highly sought-after scientists. These are entry-level applicants, and there is no shortage of applicants for…
For the purpose of debate only, I yield the customary 30 minutes to the Congresswoman from Pennsylvania (Ms. Scanlon), pending which I yield myself such time as I may consume. During consideration of this resolution, all time yielded is…
I led a letter to the FDA asking them to reclassify naloxone to where you could get it without a prescription.
I urge all my fellow colleagues to join me in supporting H.R. 766 and ensuring that we continue to prioritize preventive healthcare initiatives for the betterment of all Americans, and I reserve the balance of my time.





